Bocom initiated coverage of Bristol Myers with a Sell rating and $33.10 price target.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BMY:
- Bristol Myers price target lowered to $43 from $47 at UBS
- Truist biotech analyst holds an analyst/industry conference call
- Bristol Myers price target lowered to $41 from $43 at Barclays
- VYNE Therapeutics announces appointment of Banerjee as SVP
- Ex-Dividend Date Nearing for These 10 Stocks – Week of July 1, 2024